in Haematology, 2026 Practice Changing Updates
Abstract
Practice Changing Updates in Hematology (PCUH 2026): Advancing the Future of Hematology Through Knowledge, Collaboration and Innovation
The Practice Changing Updates in Hematology (PCUH 2026) conference was held from 9–11 October 2026 at the Pearl Continental Hotel, Rawalpindi, bringing together hematologists, medical oncologists, bone marrow transplant (BMT) specialists, researchers, nurses and postgraduate trainees from Pakistan and abroad. The well-attended hybrid conference provided an important platform for scientific exchange, professional networking and discussion of the latest developments shaping the future of hematology.
The conference was hosted by the Pakistan Blood and Marrow Transplantation Society (PBMT) and organised by the Armed Forces Bone Marrow Transplant Centre (AFBMTC), Rawalpindi. Its theme, “Practice Changing Updates in Hematology: Treatment Sequencing Insights from ASH 2025, ASCO 2026 and EHA 2026,” reflected its emphasis on translating the latest international evidence into clinical practice.
An International Scientific Gathering
A major strength of PCUH 2026 was the participation of distinguished national and international faculty. Experts from leading institutions in the United States, United Kingdom, China, Saudi Arabia, Brazil and other countries joined Pakistani specialists in a comprehensive scientific programme. The hybrid format extended the conference's reach beyond the physical venue, enabling wider participation and facilitating international academic interaction.
The inaugural session featured addresses by prominent leaders in hematology and transplantation, followed by a keynote lecture on the changing landscape of stem cell transplantation. The sessions highlighted how rapidly evolving evidence, new therapeutic options and advances in cellular therapies are reshaping the management of blood disorders and malignancies.
The scientific programme covered a broad spectrum of contemporary hematology. Sessions addressed high-grade lymphomas, chronic myeloid leukaemia (CML), chronic lymphocytic leukaemia (CLL), chronic myelomonocytic leukaemia (CMML), acute myeloid leukaemia (AML), aplastic anaemia, paroxysmal nocturnal haemoglobinuria (PNH), and complications of haematopoietic stem cell transplantation (HSCT).
Particular attention was devoted to CAR-T-cell therapy, haploidentical transplantation in aplastic anaemia, graft-versus-host disease (GVHD), and evolving treatment strategies for acute leukaemia and lymphoma. Discussions on treatment sequencing, transplant indications and evidence-based management in Pakistan were especially relevant, given the challenges of implementing sophisticated therapies in resource-constrained settings.
The research abstract session offered a valuable opportunity for clinicians and researchers to present clinical experience and emerging evidence. Topics included transplantation outcomes, treatment strategies for AML and lymphoma, and therapeutic approaches to transfusion-dependent thalassaemia. These presentations demonstrated the importance of locally generated research in informing clinical decisions and improving patient care.
Learning Beyond the Lecture Hall
PCUH 2026 placed considerable emphasis on interactive learning and multidisciplinary collaboration. Panel discussions following scientific presentations enabled delegates to examine difficult clinical questions, compare institutional practices and explore how international recommendations could be adapted to local circumstances.
Dedicated nursing and data management sessions further broadened the scope of the conference. These sessions reinforced the importance of coordinated teamwork among physicians, nurses, laboratory professionals and data managers in delivering high-quality haematology and transplant services.
One of the highlights was the HIMMEL fellowship-trainee quiz, which brought an element of friendly competition to the academic programme. The quiz provided trainees with an opportunity to demonstrate their knowledge, clinical reasoning and ability to respond to challenging questions in a competitive setting.
PATHWEL was represented by Dr Aliah and Dr Mehroze, whose commendable performance secured a prize for their team. Their achievement was a source of pride for PATHWEL and reflected the value of continued academic preparation and participation in professional forums.
Exhibition and Institutional Representation
The conference also featured an exhibition by pharmaceutical companies, providing delegates with opportunities to learn about therapeutic developments, new treatment options and advances relevant to haematology and transplantation. The exhibition complemented the scientific sessions by encouraging interaction between healthcare professionals and industry representatives.
A separate poster exhibition showcased research and clinical work, allowing participants to engage with scientific findings beyond the formal presentations. Such platforms are important for encouraging research, sharing institutional experiences and fostering collaboration among professionals at different stages of their careers.
PATHWEL also established a dedicated stall at the conference. This provided an opportunity to introduce the centre, highlight its work in haematology and bone marrow transplantation, and interact with colleagues from other institutions. The stall helped strengthen PATHWEL's professional visibility and offered a platform to share its experience in providing specialised blood disease services in Pakistan.
Networking, Camaraderie and Lasting Connections
The conference programme extended beyond academic sessions to include two dinner evenings for national and international delegates. These gatherings provided a relaxed setting for colleagues to reconnect, establish new professional relationships and exchange experiences across institutions and countries.
Such informal interactions are an important component of international conferences. They encourage collaboration, facilitate the sharing of expertise and often lay the groundwork for future research partnerships and professional initiatives.
A Step Forward for Hematology in Pakistan
PCUH 2026 was a valuable gathering that combined scientific excellence, interactive learning, research presentations and professional networking. By bringing international advances into conversation with the realities of Pakistani clinical practice, the conference addressed an important need: ensuring that progress in hematology translates into meaningful improvements in patient care.
For PATHWEL, participation in the conference was an opportunity to remain abreast of rapidly evolving developments, strengthen institutional connections and support the academic growth of its team. The success of Dr Aliah and Dr Mehroze in the fellowship quiz added a particularly encouraging note to the centre's participation.
The conference concluded with renewed emphasis on collaboration, evidence-based practice and continued professional development. Its central message was clear: advancing hematology requires not only scientific innovation, but also committed professionals, locally relevant research, multidisciplinary teamwork and sustained efforts to make better treatments accessible to patients who need them most.
“PCUH 2026: Advancing Together, Transforming Lives”
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Journal of Haematology and Stem Cell Research

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The licensor permits others to copy, distribute, display, and perform the work, as well as make and distribute derivative works based on it. The licensor permits others to copy, distribute, display, and perform the work for non-commercial purposes only.